Top 5 News: 11/14-11/20
1) FDA approves J&J drug for advanced multiple myeloma – Reuters, 11/16/2015
U.S. regulators have approved an experimental treatment from Johnson & Johnson that may offer hope to multiple myeloma patients who have run out of other options against the blood cancer.
2) UMass researchers achieve several ‘firsts’ in new use for CRISPR/Cas9 – BBJ, 11/16/2015
A new technique for so-called gene editing that formed the basis of well-funded Cambridge startups like Editas Medicine and CRISPR Therapeutics may have another use: Turning off genes that cause a rare form of muscular dystrophy.
3) After two-decade battle, Maynard’s AquaBounty gets FDA nod for genetically engineered salmon – BBJ, 11/19/2015
More than two decades after approaching federal regulators for approval, a Maynard company today says it now can produce and sell its genetically engineered, fast-growing salmon.
4) FDA approves nasal spray that reverses opioid overdose – STAT, 11/18/2015
A critical drug used to reverse opioid overdoses will now be sold as a nasal spray, a development that will likely broaden use of the antidote among family members and friends of addicts caught up in a growing national epidemic of drug abuse.
5) Kraft foundation gives $20 million to advance personalized medicine– Boston Globe, 11/19/2015
New England Patriots owner and philanthropist Robert Kraft is donating $20 million to advance personalized medicine, the growing field of research that holds the promise of new treatments for patients with debilitating diseases.